REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 204 filers reported holding REPLIGEN CORP in Q3 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,821,000 | +5.6% | 24,796 | +4.0% | 0.68% | -4.1% |
| Q4 2020 | $4,567,000 | -62.4% | 23,831 | -71.1% | 0.71% | -69.1% |
| Q3 2020 | $12,152,000 | +19.2% | 82,367 | -0.2% | 2.30% | +8.3% |
| Q2 2020 | $10,197,000 | -18.6% | 82,495 | -36.4% | 2.13% | -24.2% |
| Q1 2020 | $12,520,000 | +4.9% | 129,691 | +0.5% | 2.81% | +42.4% |
| Q4 2019 | $11,935,000 | +3.0% | 129,025 | -14.6% | 1.97% | -4.1% |
| Q3 2019 | $11,582,000 | -10.9% | 151,028 | -0.2% | 2.06% | -6.9% |
| Q2 2019 | $13,003,000 | +62.5% | 151,290 | +11.7% | 2.21% | +57.0% |
| Q1 2019 | $8,002,000 | +12.0% | 135,450 | +0.0% | 1.41% | -5.9% |
| Q4 2018 | $7,142,000 | -1.0% | 135,416 | +4.1% | 1.50% | +26.9% |
| Q3 2018 | $7,212,000 | +46.4% | 130,041 | +24.2% | 1.18% | +41.4% |
| Q2 2018 | $4,926,000 | – | 104,709 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |